ÄÔȱѪ

ÈÕÆÚ Title
0103 Adenosine as an important mediator of post-ischaemic neuronal stunning
0009 POSTURAL HYPOTENSION
0009 animal model-Cellular and transgenic animal models of cerebrovascular amyloidosis
0009 Stroke recovery- how the computer reprograms itself
0009 Ischaemic preconditioning of the endothelium and smooth muscle of cerebral arteries
0009 NEUROPSYCHIATRIC CONSEQUENCES OF STROKE
0009 HIF-1 and human disease
0008 Pulmonary hypertension, anorexigens and 5-HT
0008 Evaluation of Measures Used to Assess Quality of Life After Stroke
0008 GABA potentiation- a logical pharmacological approach for the treatment of acute ischaemic stroke
0008 Importance of neuroendocrine activation in chronic heart failure
0008 Galanin-alpha2-receptor interactions in central cardiovascular control
0008 Oral Platelet Glycoprotein IIb-IIIa Inhibitor, Lotrafiban, in Patients With Coronary or Cerebral Atherosclerotic Disease
0007 G20210A PRTH Gene Mutation and Other Trombophilic Polymorphisms in Patients With Cerebral Vein Thrombosis
0007 Thienopyridines or Aspirin to Prevent Stroke and Other Serious Vascular Events in Patients at High Risk of Vascular Disease
0007 No Side Effects After Low-Dose Amphetamine Administration in Stroke Rehabilitation
0006 Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women The NHANES I Epidemiologic Follow-up Study
0006 Pharmacological advance in the treatment of acute brain injury
0005 Regulation of the Cerebral Circulation
0005 Sympathetic activation in chronic heart failure
Next Last
Records 1 to 20 of 36